LifeStance Health Group, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
LifeStance Health Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • LifeStance Health Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.96M, a 90.3% increase year-over-year.
  • LifeStance Health Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$95.3M, a 49.3% increase year-over-year.
  • LifeStance Health Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$186M, a 13.6% increase from 2022.
  • LifeStance Health Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$216M, a 29.8% increase from 2021.
  • LifeStance Health Group, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$307M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$95.3M -$5.96M +$55.6M +90.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$151M -$23.3M +$22.2M +48.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$173M -$21.1M +$13.1M +38.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$186M -$45M +$1.7M +3.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$188M -$61.6M -$23.7M -62.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$164M -$45.5M +$23.2M +33.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$187M -$34.2M +$28.1M +45.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$216M -$46.7M +$61.4M +56.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$277M -$37.9M +$82.6M +68.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$360M -$68.7M +$1.31M +1.87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$361M -$62.3M -$53.6M -618% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$307M -$108M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$120M -$117M -3557% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$70M -$65.7M -1513% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$8.68M +$18.9M +68.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$3.29M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.34M Apr 14, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$27.6M Apr 1, 2020 May 14, 2020 10-Q 2021-08-12
Q1 2020 -$24.9M Jan 1, 2020 May 14, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.